Item List

Epitel, Inc., a leader in AI-driven wireless brain health technologies, announced today the closing of a $26 million Series B financing co-led by Catalyst Health Ventures and Genoa Ventures, with participation from new and existing investors. The funding will support the continued market expansion of the company's REMI® Remote EEG Monitoring System, allowing extended duration wireless EEG monitoring integrated with AI-driven event detection to improve access to neurological care.